CXCL8 and ovarian cancer: Pawlik et al. proposed IL-8 as a useful biomarker to distinguish between benign and malignant states because they reported increased serum levels of cytokines/chemokines in ovarian cancer patients compared with those in benign ovarian cystic patients [75].